It’s the latest example of insurance companies partnering with independent centers to offer lower-cost outpatient services.
Health
Supreme Court temporarily restores full access to key abortion medication
Justice Alito granted the government’s request for a stay and asked for additional briefing by next Tuesday.
Justice Dept. to ask Supreme Court to restore full access to abortion pill
Maine Gov. Janet Mills says mifepristone will remain accessible without new restrictions in the state in the wake of conflicting rulings.
Moderna says potential flu vaccine needs more study
The company is testing the vaccine in two, late-stage studies in the Southern and Northern hemispheres.
Mainers navigate shortage of critical ADHD medication
Widely known by its brand names, including Adderall, the drug has been a life-changer for people with attention-deficit/hyperactivity disorder.
Uptake of bivalent COVID-19 boosters low in Maine, but still higher than most of the country
Nearly a third of all Mainers ages 5 years and older have received the omicron-targeting bivalent booster shot compared to less than 18% of individuals nationwide. Data from the U.S. Centers for Disease Control and Prevention show that individuals who have received the bivalent booster are at significantly lower risk of hospitalization and death compared to unvaccinated individuals.
After 4-year hiatus, dispensary providing glasses to children covered by MaineCare to reopen
After a nearly four-year hiatus, a local optical center where children covered under MaineCare can get fitted for prescription glasses is reopening.
Gov. Mills tests positive for COVID-19
Sunday’s announcement represents the second time Maine’s governor has contracted COVID-19 within the past year.
Two substance use disorder recovery residences coming to Lewiston area
Johnny Clark, the owner and operator of A Hand Up in Lewiston, is opening a multiunit apartment building in Lewiston and a 10-bed recovery home for women in Sabattus.
FDA approves over-the-counter Narcan. Here’s what it means.
The U.S. Food and Drug Administration has approved over-the-counter sales of the overdose antidote naloxone, marking the first time an opioid treatment drug will be available without a prescription.